Midgard Science

Reithera

Rome, Italyreithera.comFrom their website, Nov 2026

  • GMP

Work here? Claim this listing

About

ReiThera develops and manufactures viral-vector-based genetic vaccines and advanced therapies. It supports biotech and pharmaceutical programs from early research through clinical and commercial readiness, with sites in Rome and Naples, Italy.

Services

  • Technology Development

    Transforms nucleotide or amino acid sequences and early-stage concepts into functional viral vectors for research, pre-GMP development, or GMP manufacturing.

  • Vector engineering

    Designs, engineers, optimizes, and characterizes viral vectors for vaccines and advanced therapies.

  • Plasmid design and sequence assembly

    Provides codon optimization, transgene design, plasmid construction, and sequence assembly for vector programs.

  • Recombinant seed generation

    Creates recombinant seed material for viral vector development.

  • R&D-grade vector production

    Produces vectors at research grade for early development work.

  • Pre-GMP seed production

    Generates seed material intended for pre-GMP development workflows.

  • Analytical method development

    Develops fit-for-purpose analytical methods and customized analytical strategies for vector programs.

  • Process Development

    Designs and optimizes upstream and downstream workflows for scalable viral vector manufacturing.

4 more services
  • GMP Manufacturing
  • Aseptic fill-finish
  • Quality System
  • Analytics

Capabilities

Assays and studies
  • AAV
  • Process development
  • HEK293
  • Bioreactors
  • Fill-finish
  • Analytical method development
3 more
  • Fit-for-purpose analytical methods
  • Batch release
  • In-process control
Scale and capacity
  • 2,000 L bioreactor capacity
  • 870 m² GMP production suites
  • 400 m² quality control laboratories
  • 3,470 m² total area
  • 1,500 m² newly validated expansion area
  • Up to 2 L bulk independent small-scale production area
  • Up to 30 m² cultivation area
  • Up to 3,500 vials per batch
Therapeutic areas
  • Infectious diseases
  • Oncology
  • Personalized medicine
  • Cancer immunotherapy

Instruments and platforms

  • 2,000 L bioreactors
  • 200 L disposable stirred-tank bioreactors
  • 1,000 L disposable stirred-tank bioreactors
  • 2,000 L disposable stirred-tank bioreactors
  • Fixed-bed bioreactors
  • WAVE bioreactors
  • oRABS Isolator System
  • Watson-Marlow Flexicon FCP50W Automated Filler

Modalities and species

Modalities
  • Antibody
  • Viral vector
  • Vaccine
  • Plasmid DNA
Species and models
  • HEK293
  • Duck Embryo Fibroblast-derived production platform
  • Gorilla adenovirus
  • Chimpanzee-derived adenovirus (ChAd)

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    As listed: GMP-certified facility; cGMP production suites

Details

Type
CRDMO
Based in
Rome, Italy
Sites
Naples, Italy
General enquiry
info@reithera.com on their site

Public records

Parent company
REITHERA S.R.L. · IT GLEIF

Similar labs